Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples